+ , but increased the extent of secretion due to 10 pM-Ca?+. In these experiments, run-down of secretion was more prolonged and control cells still released around 25% of their total catecholamine. The anti-Ac-calpactin ( 1 -I 5)-NH2 used was affinity-purified by chromatography o n Ac-calpactin ( 1 -1 5)-NH,-Sepharose.
actions with secretory granule and plasma membranes or whether calpactin is sufficient to act as a Ca" receptor and membrane fusogen in the presence of Ca?+. In studies in vitro secretory granules aggregated by calpactin in the presence of Ca? + only fused following other manipulations, such as the addition of arachidonic acid. Activation of chromaffin cells stimulates release of free arachidonic acid which has been implicated in exocytosis. Wc have recently found, however, that arachidonic acid release is not rcquired for Ca' + -dependent exocytosis in digitonin-permeabilized cells [21] . It may be that calpactin acts t o link secretory granules to the plasma membrane following a rise in ICa2+ 1, and that an additional component at the exocytotic site then acts as a membrane fusogen to result in exocytotic fusion and
Introduction
Annexins are a structurally related family of Ca?+-and phospholipid-binding proteins [ 1, 21. Each protein contains two structural domains: a small N-terminal domain and a core domain that is formed by either a 4-or 8-fold repeat of a conserved segment containing approximately 70 amino acids. Different annexins share little sequence similarity in the N-terminal domain, but have approximately 50% sequence identity in the core domain. The Ca"-binding sites reside in the core domain. The N-terminal domain is the site of phosphorylation of annexin 1 [3] [4] [5] and annexin 2 161 by tyrosine kinases, and the site of phosphorylation of several annexins by protein kinase C [ 7 ] . Neither the biological function of these proteins nor the role of phosphorylation is known. Recent studies have focused on their potential roles in intracellular Ca? + -mediated processes. It has been proposed that annexins also have an extracellular site of action, but additional studies are required to resolve this issue. The primary translation products predicted from annexin cDNA sequences do not contain a hydrophobic signal sequence [ 81. Structural analysis o f purified mammalian annexin proteins indicate that their Ntermini are blocked and, when determined, the blocking group was identified as an acetylation. These structural characteristics are consistent with annexins being intracellular proteins. However, certain of the annexins have been detected in low Concentrations in peritoneal exudates [8] . In fact. some o f the pivotal studies on annexins have been on proteins purified from this source [Y] . It is not known if these extracellular annexins were secreted by novel cellular pathways or were released from lysed cells. In addition to the annexins, a number of other proteins such as interleukin 1 and fibroblast growth factor have been detected in extracellular fluids, although their primary structures indicate that they should be intracellular [ 101.
To investigate possible physiological roles for extracellular annexins, and to define a system with which to study the cellular mechanism by which annexins reach an extracellular location, we screened extracellular fluids for the presence of annexin I . We found that the human prostate gland secretes high concentrations of annexin 1.
Kesiilts utid cliscirssioti
Setriitiul plasniu contains high coticetitrutiotis of urinexiti I . Immunoblot analysis of human semen identified two protein bands that reacted with polyclonal antiserum specific to annexin 1, but not with preimmune serum or immune serum preadsorbed with placental annexin 1. One immunoreactive band had the same apparent M, (35 000) as annexin 1 and thc second had a lower apparent M, (32 000). Experiments presented below identified the M,-32 000 protein as a proteolytic cleavage product of annexin 1 missing the first 29 amino acids. After centrifugation of semen, greater than !N"L, o f immunoreactivity was in the supernatant, thereby indicating that the majority of these proteins were in the seminal plasma and not within sperm or other cells. This conclusion is supported by the observation that seminal plasma from vasectomized patients contained the same amount of these immunoreactive proteins. These data are not inconsistent with a previous study that detected low concentrations o f annexin 1 in sperm cells [ 1 I]. Our studies extend this previous report and show that there is more than 100 times more annexin 1 in the seminal plasma than in sperm.
The concentrations of annexin 1 and des-( 1 -29)-annexin I in seminal plasma were estimated by comparing the immunostaining intensity of immunoreactive bands with known standards of placental annexins. Seminal plasma from five different individuals contained 10-40 pg/ml (mean 27; S.E.M. 4.8) annexin 1 and 20-50 pg/ml mean 33; S.E.M. 5.4) des-( 1-29)-annexin 1. Addition of EGTA to semen (final concentration 1 0 mM) before centrifugation did not alter the recovery of immunoreactive proteins in seminal plasma. Seminal plasma was also assayed for annexins 4 and 5. Immune serum specific to annexin 5 identified a single immunoreactive band (apparent M, 33 000) and its concentration in seminal plasma was approximately 20 pg/ml. Only trace amounts ( < 0.1 pg/ml) of annexin 4 were detected.
Extracellular proteins in semen are either secreted by the accessory sex glands or transudated from the blood. The seminal plasma to blood plasma concentration ratio of albumin provides a marker for transudation, and proteins with higher concentration ratios than albumin are assumed to be locally secreted 11 21. Blood plasma was assayed for annexins by immunoblotting and was found to contain approximately 0.05 pg of annexin 1 /ml and 0.5 pg of annexin 5/ml. No proteolytic cleavage products of annexin 1 were detected in blood plasma. The seminal plasma to blood plasma concentration ratios of annexins 1 and 5 are greater than the concentration ratio of albumin by a factor of more than lo4. This suggests that the proteins are actively secreted by the accessory sex glands.
C'huructerizutioti of secreted annexiris. The characteristics o f seminal plasma annexins were compared with those of annexins purified from intracellular sources by two-dimensional gel analysis, Ca? +-dependent phospholipid-binding activity, amino acid composition analysis and partial amino acid sequencing.
Seminal plasma was analysed by two-dimensional gel electrophoresis followed by immunoblotting with antiserum against either annexin 1 or 5. Two spots that reacted with antiserum against annexin 1 were observed. These spots had apparent M, values and pl values that are indistinguishable from those of placental annexin 1 and des-( 1 -29)-annexin I . A single spot that reacted with antiserum against annexin 5 was observed at a location expected for placental annexin 5. The two-dimensional gel system has been optimized for separating forms of annexin 1 that have undergone posttranslational modification [ 71. It can readily separate forms o f placental annexin 1 differing by one unit charge. Since the secreted and intracellular annexins had indistinguishable migrations on thi stem, their structures appear to be very s Seminal plasma annexins were purified by exploiting their reversible Ca? + -dependent binding t o phospholipids. A phospholipid affinity column [ 131 quantitatively removed annexins I and 5 and des-( 1-29)-annexin I from seminal plasma. After washing the column with Hepes buffer containing 1 mM-CaCI,, the adsorbed annexins could he recovered by elution with 5 mM-EGTA. The affinity column gave a yield of approximately 10 p g of anncxin/ml of seminal plasma.
The M,-32 000 protein that reacted with anti-annexin I was further purified from the EGTA eluate o f the phospholipid affinity column by cation exchange o n an f.p.1.c. mono S column. Five cycles of automated Edman degradation on the purified protcin yielded the sequence Gly-Gly-Pro-Gly-Scr. This corresponds t o the N-terminal sequence of intracellular annexin 1 following a proteolytic clip by plasmin [ 141.
Purified annexin 1 from seminal plasma also was subjected to structural analysis. Its amino acid composition was within experimental error of that of placental annexin 1, but it did not reveal any Edman degradation products. It, therefore, appears to have a blocked N-terminal. Structural analysis of annexin 5 purified from seminal plasma by this method yielded an identical conclusion.
Iissite source of secreted unriexitis. The extracellular location of annexins in seminal plasma and their high seminal plasma to blood plasma concentration ratios suggest an active secretion by the accessory sex glands. The secretions that make up seminal plasma are predominantly from the seminal vesicles (approximately 75%) and prostate (approximately 25%) [ 1.51. The epididymis is excluded as a possible source because the concentrations of annexins in seminal plasma are not changed by vasectomy (see above).
Seminal vesicle tissue, prostate tissue, and secretory fluids from both tissues were analysed by immunoblotting using antiserum against annexins 1, 4 and 5. Only annexin 5 was found in appreciable quantities in seminal vesicle tissue, and none of the annexins was detected in seminal vesicle fluid. However, all three annexins were present at very high levels in prostate tissue. The concentration o f each annexin was approximately 200-300 p g / g wet wt. prostate tissue. This corresponds to 0.4-0.6% of the total protein in the tissue homogenate. Anti-annexin 1 stained a single band with apparent M, 35 000 in prostate tissue. In contrast to seminal plasma, no lower M, bands were detected. Prostate fluid contained high concentrations of both the M,-35 000 (60 pg/ml) and M,-32 000 (80 pg/ml) bands with annexin 1 immunoreactivity. It also contained high concentrations of immunoreactive annexin 5 (60 pg/ml). Interestingly, only trace amounts (less than 0.1 pg/ml) of immunoreactive annexin 4 were detected in prostate fluid, despite its high level o f expression in prostate tissue. It is unlikely that annexin 4 is I ,.
secreted then degraded by endogenous proteases, because placental annexin 4 was not degraded when added to prostate fluid and incubated at 37°C. The collective concentrations of annexin 1, des-( 1 -29)-annexin 1, and annexin 5 in prostate fluid and seminal plasma were 1.3% and 0.2% of the total protein, respectively. This is consistent with their secretion by the prostate and subsequent dilution of seminal vesicle fluid.
Summary
The human prostate expresses very high concentrations of annexins 1, 4, and 5 and secretes high concentrations of annexins 1 and 5. Although the biological roles of these proteins in prostate secretions are not known, these studies emphasize the need to consider extracellular sites for physiological functions of annexins. The clear demonstration of secretion of proteins that have blocked N-termini and lack hydrophobic signal sequences raises the possibility that novel cellular secretory pathways exist. Preliminary immunohistochemical experiments in collaboration with Dr James Fallon indicate that both annexins 1 and 4 are expressed in prostate ductal secretory epithelium. Since annexin 1, but not annexin 4, is secreted, a comparison of the cellular fate of these two related proteins in the prostate may provide a useful model system for determining the structural elements that direct the secretion of proteins which lack conventional signal sequences.
Introduction
Annexin I1 (p36) is a member of the annexin family of Ca'+-and phospholipid-binding proteins (for review see . Like other proteins which belong to this multigene family, annexin I1 shows a characteristic structural feature, the so-called annexin repeat. This term describes a segment 70-80 amino acids in length which is repeated four times along the annexin I1 polypeptide chain. The annexin repeats exhibit homologies with one another not only within annexin I1 but also with other members of the family [ 1-51. Typically, a given repeat shows a higher degree of conservation between distinct members of the family than to other repeats in the same protein. The sum of the four repeats in annexin 11 forms the so-called protein core, which is resistant to mild proteolytic treatment. In the primary structure, this core is preceded by a proteinase-sensitive N-terminal tail, some 30 residues in length. Biochemical characterization of the proteolytic derivatives revealed that the protein core harbours binding sites for Ca2+, phospholipids and cytoskeletal proteins, such as F-actin and non-erythroid spectrin. Since the ability to interact with phospholipids in a Ca2 + -dependent manner is shared with all other annexins, it is believed that a highly conserved stretch of 17 amino acids (the so-called endonexin fold), which is found in each annexin repeat of every member of the family, is involved in the interaction with these ligands. The N-terminal tail of annexin 11 is not required for Ca2+-, phospholipid-or F-actin-binding, but harbours different phosphorylation sites and thus is believed to represent an important regulatory region of the molecule. Tyr-23 is phosphorylated by pp60'", while Ser-25 is a site for protein kinase C phosphorylation. Consequently, annexin 11 was originally identified as a major cytoplasmic substrate for the src-encoded tyrosine kinase (for review see [6] ).
Annexin I1 is so far the only annexin which has been shown to interact with a cellular protein ligand, p l 1, both in vitro and in vivo (for review see [3] ). Interaction leads to the formation of a tetrameric complex, which comprises two annexin 11 and two p l 1 chains. p l 1 binding is probably an important regulatory event, since it modulates properties displayed by annexin 11. While monomeric annexin I1 shows 50% binding to liposomes at 10 puM-free Ca2+, annexin 11 complexed with p l 1 only needs 10 nM-Ca? + for the same interaction [7] . Similarly, the annexin 11-pl 1 complex is able to induce chromaffin granule aggregation and even fusion of these vesicles at much lower Ca2+ concentrations than monomeric annexin I1 [8] . The pll-binding site is also located within the N-terminal tail of annexin 11. However, while the phosphorylation sites cluster between residues 20 and 30, only the 12 N-terminal amino acids are required for p l 1 binding. This region of the molecule forms an amphipathic helix with the hydrophilic face of this helix probably being the actual p l 1 contact site [9] . p l 1 itself belongs to a different multigene family showing sequence homologies to the S 100 proteins and other related polypeptides like calcyclin or the calgranulins (for review see [ 101). Members of this protein family are characterized by
